"We design and develop next generation drug delivery formulations to improve patients care."

The joint laboratory of VRI and ReForm Therapeutics, Ltd. was estabilished in 2021 based on previous successfull collaboration in the area of the development of new candidate drug delivery systems for oromucosal administration. We replace traditional routes of drug administration by providing products with a high added value for patients.

We design innovative mucoadhesive formulations to improve drug bioavailability
We perform formulation feasibility studies
We perform ex vivo testing
We perform preclinical testing on various animal models including rabbits and pigs
We develope analytical methods for drug quantification
We drive candidate products into GMP production and clinical testing in colaboration with third parties